Baxter International Given Conviction-Buy Rating at Goldman Sachs Group Inc. (BAX)
Baxter International (NYSE:BAX)‘s stock had its “conviction-buy” rating reiterated by investment analysts at Goldman Sachs Group Inc. in a note issued to investors on Wednesday, American Banking News reports. They currently have a $86.00 target price on the stock. Goldman Sachs Group Inc.’s price objective indicates a potential upside of 31.70% from the stock’s previous close.
BAX has been the subject of a number of other recent research reports. Analysts at Cowen and Company downgraded shares of Baxter International from an “outperform” rating to a “market perform” rating in a research note to investors on Wednesday. They now have a $67.00 price target on the stock. Separately, analysts at BMO Capital Markets cut their price target on shares of Baxter International from $82.00 to $77.00 in a research note to investors on Monday. They now have an “outperform” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Baxter International in a research note to investors on Friday, October 18th. They now have a $71.00 price target on the stock. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $75.88.
Baxter International (NYSE:BAX) traded down 0.31% during mid-day trading on Wednesday, hitting $65.10. 1,441,093 shares of the company’s stock traded hands. Baxter International has a one year low of $59.61 and a one year high of $74.60. The stock has a 50-day moving average of $71.65 and a 200-day moving average of $70.87. The company has a market cap of $35.335 billion and a price-to-earnings ratio of 16.54.
Baxter International (NYSE:BAX) last released its earnings data on Thursday, October 17th. The company reported $1.19 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.19. The company had revenue of $3.80 billion for the quarter, compared to the consensus estimate of $3.82 billion. During the same quarter last year, the company posted $1.14 earnings per share. Baxter International’s revenue was up 9.5% compared to the same quarter last year. On average, analysts predict that Baxter International will post $4.67 earnings per share for the current fiscal year.
Baxter International Inc (NYSE:BAX) is a global, diversified healthcare company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.